Advertisement

Topics

Hikma and Takeda sign new licensing agreement to expand product portfolio in MENA

19:00 EDT 17 Aug 2017 | Pharmaceutical Technology

Hikma Pharmaceuticals has reached an agreement with Takeda Pharmaceutical Company to expand their licensing and distribution agreement to add new products to its existing portfolio in the Middle East and North Africa (MENA).

Original Article: Hikma and Takeda sign new licensing agreement to expand product portfolio in MENA

NEXT ARTICLE

More From BioPortfolio on "Hikma and Takeda sign new licensing agreement to expand product portfolio in MENA"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...